Nicotinic acetylcholine receptors (nAChRs) mediate excitatory neurotransmission at neuron/neuron and neuron/muscle synapses. Little is known about proteins accessory to nAChRs, which may control their functional properties and thus play a role in nicotine addiction. To identify such proteins, we performed tandem affinity purification (TAP) of the levamisole receptor, a nAChR expressed in muscles and neurons. Proteins in the unseparated eluate were analyzed after tryptic digest by liquid chromatography / electrospray tandem mass spectrometry. Among the abundant proteins present were the nAChR subunits UNC-29, LEV-1, UNC-38 and UNC-63, previously implicated in formation of the levamisole receptor by genetics and electrophysiology. In addition, we found the -type nAChR subunits ACR-8, ACR-12 and ACR-13. A Tc1-insertion in
acr-8 confers nicotine resistance, just like mutations in the previously known levamisole receptor genes, while a deletion in
acr-12 does not. GFP-fusions of ACR-8 and ACR-13 are expressed in muscles and neurons, whereas ACR-12 is exclusively neuronal. The novel subunits may thus be components of distinct sub-populations of the levamisole receptor, possibly replacing the -subunits UNC-38 and/or UNC-63. Consistently, ACR-8 and ACR-12 co-localize in post-synaptic receptor clusters with UNC-38, while UNC-38 is also present in clusters not containing ACR-8 or ACR-12. Many other proteins were co-purified with the levamisole receptor, among them the calcineurin A subunit TAX-6 and calmodulin (CMD-1). Calcineurin is a Ca2+-activated phosphatase comprising catalytic A and regulatory B subunits, as well as calmodulin. Vertebrate calcineurin was found to reduce the rate by which nAChRs recover from agonist-induced desensitization. Consistently,
tax-6(
p675) and
cnb-1(
jh103) mutants (calcineurin B subunit), or animals in which calmodulin was knocked down by RNAi, are hypersensitive to nicotine. TAX-6::GFP and antibody-labeled UNC-38 are found in the same nervecord processes, in agreement with a direct interaction. To address possible functions in cholinergic neurotransmission of other proteins co-purified with the levamisole receptor, we are using RNAi. So far, of 12 candidates that we knocked down by RNAi, 5 exhibit increased sensitivity to nicotine. We are further assessing possible changes of levamisole receptor abundance and localization in these knock-down animals.